Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sonazoid vs SonoVue for liver focal lesions CEUS diagnosis
CTR20131616Phase 3Completed
- Sponsor
- GE HealthCare
- Start
- Apr 2014
- Modality
- Acoustic/Optical: Sonoporation, laser photoporation → Physical Methods → Gene Addition/Replacement → Gene Therapies, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of sonazoid in focal liver lesion, sponsored by GE HealthCare. Started Apr 2014; status: completed.
02
Drugs
sonazoid
03
Conditions
focal liver lesion
Beyond the preview
Go deeper on CTR20131616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131616.